Skip to content
Moderna CEO Stéphane Bancel testified on Capitol Hill yesterday during a hearing that one U.S. Senator compared to a “show trial” and “public shaming” […]
Moderna hearing on Capitol Hill is ‘more like a show trial,’ says U.S. Senator Read More »
As Moderna CEO Stéphane Bancel heads to Capitol Hill to testify before the Health, Education, Labor, and Pensions (HELP) Committee, experts are watching to
To protect innovation, we need to protect Bayh-Dole, says one expert Read More »
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with a misleading title, “Taxpayers
4 questions with Moderna President Stephen Hoge Read More »
While awaiting for the public hearing on the proposed expansion of the COVID IP waiver that the U.S. International Trade Commission (USITC) has scheduled
IP waiver directly threatens U.S. medical innovation, biomanufacturing Read More »
While animal activists oppose animal testing on moral grounds, the biotech industry knows that alternative technology can provide more accurate and less expensive screening
Biotech wants to reduce animal testing and FDA is now tasked with helping Read More »
The importance of data and the growing use of technology – such as wearables and other mobile devices and sensors that can collect and
How biotech is addressing sources of bias in studies using real-world evidence Read More »
The makers of more than a dozen prescription drugs covered by Medicare are seeing the first impacts of the Inflation Reduction Act (IRA) passed
CMS announces penalties on 27 prescription drugs, draft guidance on price controls Read More »
Biotechnology Innovation Organization (BIO) members Bristol Myers’, Pfizer’s, and AbbVie’s drugs “are likely to be among 10 big-selling medicines subject to U.S. price negotiations
U.S. drug price negotiation already affecting Bristol Myers, Pfizer, AbbVie Read More »
America’s largest integrated healthcare system, the Veterans Health Administration (VHA), will be providing coverage of LEQEMBI (lecanemab-irmb) “to veterans living with early stages of
VHA is the first major insurer to cover Alzheimer’s drug LEQEMBI Read More »
While it deliberates on whether to support the expansion of the international waiver of IP protections for COVID-19 therapeutics and diagnostics, the United States
Last chance for public hearing on the COVID IP waiver expansion Read More »
